AUB ScholarWorks

Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 years and older: Results of an open-label, randomized, controlled trial

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search AUB ScholarWorks


My Account